MetaADEDB 2.0 @ LMMD
mizoribine
(HZQDCMWJEBCWBR-UUOKFMHZSA-N)
Structure
SMILES
OC[C@H]1O[C@H]([C@@H]([C@@H]1O)O)n1cnc(c1O)C(=O)N
Type(s)
Investigational
Molecular Formula:
C9H13N3O6
Molecular Weight:
259.216
Log P:
-2.0006
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
5
TPSA:
151.06
CAS Number(s):
50524-49-7; 50924-49-7
Synonym(s)
1.
mizoribine
2.
bredinin
3.
mizoribine 5'-monophosphate
External Link(s)
MeSHC010052
PubChem Compound104762
BindingDB68669
ChEBI31858
CHEMBLCHEMBL245019
DrugBankDB12617
DrugCentral3363
KEGGdr:D01392
Therapeutic Target DatabaseD0G5AG
ZINC3812887
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Abdominal PainOFFSIDES
2Abnormal visionOFFSIDES
3AbscessOFFSIDES
4Acute prerenal failureOFFSIDES
5AdenocarcinomaOFFSIDES
6AgraphiaOFFSIDES
7Alanine Aminotransferase IncreasedOFFSIDES
8Altered state of consciousnessOFFSIDES
9Amniotic fluid volume decreasedOFFSIDES
10AnorexiaOFFSIDES
11Anti-erythrocyte antibody positiveOFFSIDES
12Anti-platelet antibody negativeOFFSIDES
13Antibody test abnormalOFFSIDES
14Antiphospholipid SyndromeOFFSIDES
15Antithrombin III decreasedOFFSIDES
16ApathyOFFSIDES
17Aspartate aminotransferase decreasedOFFSIDES
18Atlantoaxial instabilityOFFSIDES
19BK virus infectionOFFSIDES
20Band neutrophil percentage increasedOFFSIDES
21Beta 2 microglobulin urine increasedOFFSIDES
22Blood GlucoseOFFSIDES
23Blood albumin decreasedOFFSIDES
24Blood alkaline phosphatase increasedOFFSIDES
25Blood amylase increasedOFFSIDES
26Blood beta-D-glucan increasedOFFSIDES
27Blood cholesterolOFFSIDES
28Blood creatinine decreasedOFFSIDES
29Blood creatinine increasedOFFSIDES
30Blood fibrinogen increasedOFFSIDES
31Blood immunoglobulin G increasedOFFSIDES
32Blood lactate dehydrogenase increasedOFFSIDES
33Blood urea increasedOFFSIDES
34Blood uric acidOFFSIDES
35Blood urine presentOFFSIDES
36Body height below normalOFFSIDES
37CYTOMEGALOVIRUS ANTIGENOFFSIDES
38Carcinoembryonic antigen increasedOFFSIDES
39Cardioactive drug levelOFFSIDES
40CataractOFFSIDES
41Cell marker increasedOFFSIDES
42Chronic ulcerative colitisOFFSIDES
43Completed SuicideOFFSIDES
44Cutaneous CandidiasisOFFSIDES
45Cytomegalovirus antibody positiveOFFSIDES
46Cytomegalovirus enterocolitisOFFSIDES
47DebridementOFFSIDES
48Depressed Level of ConsciousnessOFFSIDES
49Device related infectionOFFSIDES
50DiabetesOFFSIDES
51DiarrheaOFFSIDES
52Diffuse Large B-Cell LymphomaOFFSIDES
53Disseminated Intravascular CoagulationOFFSIDES
54Diverticular perforationOFFSIDES
55Dry skinOFFSIDES
56Duodenal ulcer perforationOFFSIDES
57EcthymaOFFSIDES
58EnterocolitisOFFSIDES
59Eosinophil percentage decreasedOFFSIDES
60EpididymitisOFFSIDES
61Epstein-Barr virus associated lymphoproliferative disorderOFFSIDES
62Feeling abnormalOFFSIDES
63Focal glomerulosclerosisOFFSIDES
64Gamma-Glutamyltransferase IncreasedOFFSIDES
65Gastric ulcerOFFSIDES
66Gastrointestinal erosionOFFSIDES
67Gaze palsyOFFSIDES
68GlaucomaOFFSIDES
69GlobulinuriaOFFSIDES
70Grip strengthOFFSIDES
71HBV-DNA polymerase increasedOFFSIDES
72HaemoconcentrationOFFSIDES
73HemiparesisOFFSIDES
74HepatectomyOFFSIDES
75Hepatitis C antibody positiveOFFSIDES
76Hepatitis COFFSIDES
77HepatitisOFFSIDES
78Histiocytosis haematophagicOFFSIDES
79HypoxiaOFFSIDES
80Intestinal PerforationOFFSIDES
81Intracardiac massOFFSIDES
82JC virus infectionOFFSIDES
83LaparotomyOFFSIDES
84LeukoaraiosisOFFSIDES
85Lip erosionOFFSIDES
86LithotripsyOFFSIDES
87Lung AbscessOFFSIDES
88Lymph Node TuberculosisOFFSIDES
89Lymphocyte percentage decreasedOFFSIDES
90LymphomaOFFSIDES
91MalabsorptionOFFSIDES
92Malignant ascitesOFFSIDES
93Megakaryocytes increasedOFFSIDES
94Mental RetardationOFFSIDES
95Monocyte percentage increasedOFFSIDES
96MyelitisOFFSIDES
97NasopharyngitisOFFSIDES
98Neoplasms, Experimental2239571CTD
99Nephritic syndromeOFFSIDES
100Nephritis3656695CTD
101Nephrotic Syndrome9323293CTD
OFFSIDES
102Neuroleptic Malignant SyndromeOFFSIDES
103OliguriaOFFSIDES
104Oral mucosal exfoliationOFFSIDES
105OrthopneaOFFSIDES
106OsteoporosisOFFSIDES
107PancreatitisOFFSIDES
108PanniculitisOFFSIDES
109PeriodontitisOFFSIDES
110Pneumocystis jiroveci pneumoniaOFFSIDES
111PneumothoraxOFFSIDES
112Protein total decreasedOFFSIDES
113Proteinuria8919236
20502051
CTD
114Prothrombin level decreasedOFFSIDES
115RalesOFFSIDES
116Renal graft lossOFFSIDES
117Renal tubular atrophyOFFSIDES
118Renal tubular necrosisOFFSIDES
119Respiratory FailureOFFSIDES
120Rheumatoid factor increasedOFFSIDES
121SequestrectomyOFFSIDES
122Sjogren's SyndromeOFFSIDES
123Skin test positiveOFFSIDES
124Status EpilepticusOFFSIDES
125Subcutaneous AbscessOFFSIDES
126Systemic mycosisOFFSIDES
127ThoracotomyOFFSIDES
128Thrombotic cerebral infarctionOFFSIDES
129TonsillectomyOFFSIDES
130Transaminases increasedOFFSIDES
131Upper respiratory tract inflammationOFFSIDES
132Ureteric anastomosis complicationOFFSIDES
133Urinary tract inflammationOFFSIDES
134Vertebral artery occlusionOFFSIDES
135Vocal Cord ParalysisOFFSIDES
136Weight GainOFFSIDES
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.